Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.60 |
| ▸ | NPY1R | P25929 | 7/20 | 0.60 |
| ▸ | NPY2R | P49146 | 5/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 8/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29988484 | 0.96 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL30450301 | 0.96 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29531433 | 0.96 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29531172 | 0.96 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29780055 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL31256959 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL31512205 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29637467 | 0.93 | NPY4R (0.66) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL31575310 | 0.93 | NPY4R (0.60) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL13563452 | 0.93 | NPY4R (0.67) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210106506-A1 | METHODS FOR COSMETIC SKIN REMODELING | ELC MANAGEMENT LLC | 2021-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210106506-A1 | METHODS FOR COSMETIC SKIN REMODELING | CUTA, PLOD3, KRT18 | NPY4R 4427/4885NPY1R 4256/4885NPY2R 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.